These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23484394)

  • 1. [Detection of the adventitious agents in the evaluation of vaccine safety].
    Augustynowicz E; Lutyńska A
    Przegl Epidemiol; 2012; 66(4):643-9. PubMed ID: 23484394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of PCR-based assays for the detection of the adventitious agent porcine circovirus type 1 (PCV1) in vaccines, and for confirming the identity of cell substrates and viruses used in vaccine production.
    Kumar D; Beach NM; Meng XJ; Hegde NR
    J Virol Methods; 2012 Jan; 179(1):201-11. PubMed ID: 22079617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.
    Yu Q; Liu Y; Du J; Liu Y; Zhang L; Guo T
    J Gen Virol; 2018 Jan; 99(1):103-108. PubMed ID: 29165219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of porcine circovirus contamination in human vaccines.
    Gilliland SM; Forrest L; Carre H; Jenkins A; Berry N; Martin J; Minor P; Schepelmann S
    Biologicals; 2012 Jul; 40(4):270-7. PubMed ID: 22402185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of porcine circovirus type 1 in commercial pig vaccines using polymerase chain reaction.
    Quintana J; Segalés J; Calsamiglia M; Domingo M
    Vet J; 2006 May; 171(3):570-3. PubMed ID: 16624728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Need for new technologies for detection of adventitious agents in vaccines and other biological products.
    Mallet L; Gisonni-Lex L
    PDA J Pharm Sci Technol; 2014; 68(6):556-62. PubMed ID: 25475629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine, Rotarix: approach and outcome.
    Dubin G; Toussaint JF; Cassart JP; Howe B; Boyce D; Friedland L; Abu-Elyazeed R; Poncelet S; Han HH; Debrus S
    Hum Vaccin Immunother; 2013 Nov; 9(11):2398-408. PubMed ID: 24056737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of spiked porcine circovirus during the manufacture of a Vero cell-derived vaccine.
    Lackner C; Leydold SM; Modrof J; Farcet MR; Grillberger L; Schäfer B; Anderle H; Kreil TR
    Vaccine; 2014 Apr; 32(18):2056-61. PubMed ID: 24560672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines.
    Ma H; Shaheduzzaman S; Willliams DK; Gao Y; Khan AS
    Vaccine; 2011 Oct; 29(46):8429-37. PubMed ID: 21835219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three Rs potential in the development and quality control of immunobiologicals.
    Halder M
    ALTEX; 2001; 18 Suppl 1():13-47. PubMed ID: 11854853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adventitious agents in viral vaccines: lessons learned from 4 case studies.
    Petricciani J; Sheets R; Griffiths E; Knezevic I
    Biologicals; 2014 Sep; 42(5):223-36. PubMed ID: 25135887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cells and biological reagents for adventitious agents using degenerate primer PCR and massively parallel sequencing.
    McClenahan SD; Uhlenhaut C; Krause PR
    Vaccine; 2014 Dec; 32(52):7115-21. PubMed ID: 25454874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of porcine circovirus type 1 detected in Rotarix vaccine.
    Baylis SA; Finsterbusch T; Bannert N; Blümel J; Mankertz A
    Vaccine; 2011 Jan; 29(4):690-7. PubMed ID: 21093497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Issues of biological assays for viral vaccines.
    Lee CK
    Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of adventitious viruses in biologicals--a rare occurrence.
    Nims RW
    Dev Biol (Basel); 2006; 123():153-64; discussion 183-97. PubMed ID: 16566443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP
    Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of PCR technology in vaccine product development.
    Wolf JJ; Wang L; Wang F
    Expert Rev Vaccines; 2007 Aug; 6(4):547-58. PubMed ID: 17669009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LUX real-time PCR assay for the detection of porcine circovirus type 2.
    Vilcek S; Vlasakova M; Jackova A
    J Virol Methods; 2010 May; 165(2):216-21. PubMed ID: 20138916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.